Clinical Trial

Artichoke By-products Rich in Hydroxycinnamic Acids and Mediterranean Diet for Type 2 Diabetes Prevention.

Study acronym: ARTI-UP
Recruiting
View on ClinicalTrials.gov →
Summary
The ARTI-UP study evaluates whether daily consumption of a supplement made from artichoke by-products, rich in hydroxycinnamic acids (HCAs), in combination with an energy-restricted Mediterranean diet (erMeDiet), can improve glycaemic control, reduce insulin resistance and contribute to weight loss in subjects with overweight or obesity. In addition, it seeks to understand the biological mechanisms involved using omic techniques and to establish predictive biomarkers that will enable progress towards personalised nutrition strategies.
Protocol Amendment History 1 change
notable Primary completion pushed: 2027-07 -> 2027-12 2026-04-30
Trial Details
NCT Number NCT07415720
Lead Sponsor Clinica Universidad de Navarra, Universidad de Navarra
Collaborators: University of Navarra, Hospital of Navarra
Conditions Diabete Type 2, Obesity & Overweight, Insulin Resistance Syndrome
Enrollment 150 participants
Start Date 2026-05
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-29